HS-410

· Heat Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-410, covering 2020-02-17 to 2020-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT [Phase 1, Phase 2]